Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Glycopyrrolate, and what generic alternatives are available?

Glycopyrrolate is a drug marketed by Watson Labs, Appco Pharma Llc, Natco Pharma Ltd, Vintage Pharms, Rising Pharms Inc, Nexgen Pharma, Luitpold, Hikma Intl Pharms, Sun Pharm Inds Ltd, Dr Reddys Labs Ltd, Par Pharm, Hikma Farmaceutica, Corepharma, Teva Parenteral, Abraxis Pharm, Aurolife Pharma Llc, Stason Pharms, Hospira, and Leading Pharma Llc. and is included in twenty-four NDAs.

The generic ingredient in GLYCOPYRROLATE is glycopyrrolate. There are fifteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.

Summary for Tradename: GLYCOPYRROLATE

Suppliers / Packagers: see list26
Bulk Api Vendors: see list50
Clinical Trials: see list41
Patent Applications: see list1,980
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GLYCOPYRROLATE at DailyMed

Pharmacology for Tradename: GLYCOPYRROLATE

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stason Pharms
TABLET;ORAL091182-002Feb 3, 2014AARXNoNo► Subscribe► Subscribe
Abraxis Pharm
INJECTABLE;INJECTION088475-001Jun 12, 1984DISCNNoNo► Subscribe► Subscribe
INJECTABLE;INJECTION089393-001Jun 15, 1988DISCNNoNo► Subscribe► Subscribe
Aurolife Pharma Llc
TABLET;ORAL202675-001Apr 15, 2013AARXNoNo► Subscribe► Subscribe
Watson Labs
TABLET;ORAL086900-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus